83 related articles for article (PubMed ID: 2834489)
21. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A
Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842
[TBL] [Abstract][Full Text] [Related]
22. [Successful therapy of consumption coagulopathy in EPH gestosis with multiple organ failure].
Schregel W; Straub H; Wölk G; Schneider R
Anasth Intensivther Notfallmed; 1984 Aug; 19(4):201-3. PubMed ID: 6496888
[TBL] [Abstract][Full Text] [Related]
23. [Therapy of consumption coagulopathies].
Künzer W
Monatsschr Kinderheilkd; 1988 Dec; 136(12):788-94. PubMed ID: 3070363
[TBL] [Abstract][Full Text] [Related]
24. [The status of blood coagulation preparations within the scope of modern hemotherapy in surgical patients].
Kretschmer V
Beitr Infusionsther; 1989; 24():134-50. PubMed ID: 2481530
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of early detection and management of disseminated intravascular coagulation among Alexandria University pediatric intensive care patients.
El-Nawawy A; Abbassy AA; El-Bordiny M; Essawi S
J Trop Pediatr; 2004 Dec; 50(6):339-47. PubMed ID: 15537719
[TBL] [Abstract][Full Text] [Related]
26. [Hepatic coagulopathy--principles and therapeutic statements].
Thaler E; Kleinberger G
Leber Magen Darm; 1982 Oct; 12(5):193-7. PubMed ID: 7182699
[TBL] [Abstract][Full Text] [Related]
27. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
Fox NS; Laughon SK; Bender SD; Saltzman DH; Rebarber A
Obstet Gynecol; 2008 Oct; 112(4):884-9. PubMed ID: 18827132
[TBL] [Abstract][Full Text] [Related]
28. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study.
Youssef WI; Salazar F; Dasarathy S; Beddow T; Mullen KD
Am J Gastroenterol; 2003 Jun; 98(6):1391-4. PubMed ID: 12818286
[TBL] [Abstract][Full Text] [Related]
29. Laboratory evaluation of the effect of prophylaxis for thromboembolism with fractionated heparin in patients undergoing laparoscopic cholecystectomy.
Martínez Ramos C; López Pastor A; Núñez Peña JR; Ruiz de Gopegui M; Sanz López R; Jorgensen T; Pastor L; Tamames S
Rev Esp Enferm Dig; 2000 Jan; 92(1):27-35. PubMed ID: 10749595
[TBL] [Abstract][Full Text] [Related]
30. [Intensive therapy of DIC-syndrome in patients with acute renal insufficiency caused by long-term crush syndrome].
Mikhaĭlov AA; Dvoretskiĭ LI; Kuznetsova OP; Iaroslavtseva GN; Vorob'ev PA; Sura OV; Miagkov AV; Medvedeva TP; Bogachev VV; Sukhomlinova LV
Klin Med (Mosk); 1991 May; 69(5):80-4. PubMed ID: 1857087
[TBL] [Abstract][Full Text] [Related]
31. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL
Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456
[TBL] [Abstract][Full Text] [Related]
32. [Long-term treatment with low molecular weight heparin, of chronic disseminated intravascular coagulation].
García Fernández JR; López Berenguel F; Ais C
An Med Interna; 2003 Apr; 20(4):191-4. PubMed ID: 12768833
[TBL] [Abstract][Full Text] [Related]
33. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
34. [Biological monitoring of treatment with low molecular weight heparin].
Aiach M; Sié P
Ann Biol Clin (Paris); 1988; 46(9):715-8. PubMed ID: 2851948
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation.
Mischke R; Fehr M; Nolte I
Res Vet Sci; 2005 Aug; 79(1):69-76. PubMed ID: 15894027
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
37. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of blood coagulation disorders in patients with chronic renal insufficiency].
Vorob'ev PA; Granich LP; Ksenzenko BL; Krutoiarskaia MI; Popova NS
Ter Arkh; 1984; 56(6):114-8. PubMed ID: 6474368
[TBL] [Abstract][Full Text] [Related]
39. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
Scheuch G; Brand P; Meyer T; Herpich C; Müllinger B; Brom J; Weidinger G; Kohlhäufl M; Häussinger K; Spannagl M; Schramm W; Siekmeier R
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
[TBL] [Abstract][Full Text] [Related]
40. [Prevention of thromboembolism with low molecular weight heparin (Fragmin) in obstetrics].
Krauss T; Rath W; Dittmer U; Kuhn W
Z Geburtshilfe Perinatol; 1994 Aug; 198(4):120-5. PubMed ID: 7975797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
